000 01240 a2200325 4500
005 20250516102516.0
264 0 _c20120927
008 201209s 0 0 eng d
022 _a1538-3601
024 7 _a10.1001/archophthalmol.2011.1914
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFriberg, Thomas R
245 0 0 _aSystemic and ocular risks associated with therapies for macular degeneration: clarification vs confusion.
_h[electronic resource]
260 _bArchives of ophthalmology (Chicago, Ill. : 1960)
_cJun 2012
300 _a806-7; author reply 807 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHemorrhage
_xmortality
650 0 4 _aHumans
650 0 4 _aMacular Degeneration
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMyocardial Infarction
_xmortality
650 0 4 _aPhotochemotherapy
650 0 4 _aStroke
_xmortality
700 1 _aShah, Veeral
700 1 _aBilonick, Richard A
773 0 _tArchives of ophthalmology (Chicago, Ill. : 1960)
_gvol. 130
_gno. 6
_gp. 806-7; author reply 807
856 4 0 _uhttps://doi.org/10.1001/archophthalmol.2011.1914
_zAvailable from publisher's website
999 _c21949239
_d21949239